Related Experiment Video
Updated: Jan 24, 2026

Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
Published on: June 29, 2017
Hypervirulent Klebsiella pneumoniae
Thomas A Russo1,2,3,4, Candace M Marr5,6
1Department of Medicine, University at Buffalo-State University of New York, Buffalo, New York, USA trusso@buffalo.edu.
Hypervirulent Klebsiella pneumoniae (hvKp) causes severe infections globally. New biomarkers can now differentiate hvKp from classical strains, aiding diagnosis and treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Hypervirulent Klebsiella pneumoniae (hvKp) is a distinct pathotype exhibiting increased virulence compared to classical K. pneumoniae (cKp).
- hvKp infections, prevalent in the Asia-Pacific region but increasingly global, often originate in the community and can lead to severe, multifocal disease.
- This pathotype demonstrates a propensity for central nervous system infections and endophthalmitis, necessitating prompt, site-specific interventions.
Purpose of the Study:
- To highlight the evolving threat of hvKp infections.
- To discuss the genetic underpinnings of hvKp hypervirulence.
- To address the current diagnostic gap in clinical laboratories for differentiating hvKp from cKp.
Main Methods:
- Review of genetic factors associated with hvKp, including virulence plasmids and integrative conjugal elements.
- Analysis of established hvKp virulence factors such as increased capsule and aerobactin production.
- Examination of emerging antimicrobial resistance patterns and the emergence of novel hvKp strains through acquisition of virulence determinants.
Main Results:
- hvKp strains possess specific genetic determinants, often on large plasmids, contributing to their hypervirulence.
- Increased capsule and aerobactin production are key factors in hvKp pathogenesis.
- hvKp strains are developing antimicrobial resistance, and new strains emerge from drug-resistant cKp acquiring hvKp traits.
Conclusions:
- Clinical laboratories currently lack the ability to distinguish between hvKp and cKp.
- Emerging biomarkers and quantitative siderophore production assays show promise for accurate hvKp identification.
- Development of a diagnostic test would significantly improve patient care, epidemiological surveillance, and research.
More Related Videos
09:49Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment